Sweetgreen: Same-Store Sales And Margin Collapse Make This A Hold, Not A Dip Buy

Sweetgreen dropped 15% in after-hours trading Thursday and has lost 27% in July, now sitting at $5.87 with a market cap of roughly $700 million. The stock is down 86% from its peak in late 2024. The natural impulse after a selloff of that magnitude is to ask whether the panic has gone too far.

The answer is no. Sweetgreen's second-quarter earnings on August 6 exposed a business where same-store sales continue to bleed, restaurant-level margins collapsed 580 basis points, and management slashed its full-year outlook. The cyclospora outbreak is the fresh headline, but the underlying unit-economics problem predates it. This is not a dip-buy setup. It's a Hold until comparable sales actually stabilize and margins show a floor.

What the quarter actually shows

Revenue of $192.7 million, up 4% year-over-year, looks deceptively orderly. The growth came entirely from new stores — 287 locations now, with four opened in the quarter — offsetting an $11.2 million decline at existing restaurants. Strip out expansion and the core business shrank. Wall Street had forecast revenue near $194.9 million to $201.9 million; both estimates were missed.

Same-store sales declined 6.2%, down from an 11.2% traffic-driven drop in the first quarter. That improvement is worth noting — transaction declines narrowed from 11.2% in Q1 to roughly flat by June — but the second-half of the 6.2% decline came from product mix, which fell 4.2%. Management attributed this to the lower-priced wraps launched in May and the lapping effect of last year's Ripple Fries addition. In other words, the company is selling more of the cheaper items. That is a traffic stabilizer but a margin poison.

The margin picture is where this gets ugly. Restaurant-level operating margin — the core profitability metric for restaurant chains, measuring profit generated at each location before corporate overhead — fell to 13.1% from 18.9% a year earlier, a drop of 580 basis points. Restaurant-level profit fell to $25.2 million from $35.1 million. Food, beverage, and packaging costs rose 210 basis points to 29.8% of revenue. Labor costs rose 170 basis points to 29.2%. Management confirmed the company took no menu price increases during the quarter and that prices have trailed industry inflation since 2019.

For context, Cava — the closest direct competitor in fast-casual — reported restaurant margins above 21% for the same quarter. Sweetgreen's margin is well below the 20% threshold that typically supports sustainable fast-casual expansion.

Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, a proxy for operational cash generation) turned slightly negative at a $0.2 million loss, compared to $6.4 million of profit a year earlier. Diluted net loss widened to -$0.22 per share versus a $0.10-to-$0.13 loss estimate.

The cyclospora overhang

A multistate cyclospora outbreak linked to Taylor Farms iceberg lettuce began in mid-July, after the Q2 reporting period. Sweetgreen does not use iceberg lettuce, but as the salad-first brand, it absorbed the consumer fear. Foot traffic data from Placer.ai showed a one-week drop after the news broke, with some recovery afterward. A separate jalapeño recall compounded the disruption.

Management quantified the expected hit: approximately 600 basis points of damage to Q3 comparable sales, a 200-to-300-basis-point drag on full-year comps, 100-to-150 basis points of restaurant-level margin pressure, and $7 million to $10 million of EBITDA reduction. That is a meaningful but finite blow — the kind of temporary consumer scare that fades as the outbreak resolves.

The cyclospora outbreak is the catalyst for the latest sell-off, not the root cause of the business deterioration.

Guidance tells the real story

The revised full-year 2026 outlook is what separates a temporary scare from a structural problem:

• Comparable sales: expected to decline 7% to 8% for the full year
• Restaurant-level margin: 10.5% to 11.0% (down from 13.1% in Q2 and 18.9% a year ago)
• Adjusted EBITDA: a projected loss of $23 million to $27 million
• Store growth: approximately 13 net new openings, with management signaling an even more conservative pace for 2027

Management assumes Q3 same-store sales will take a 6-to-7 percentage-point hit from the outbreak, with only a partial recovery in Q4. The low-end recovery scenario assumes some bounce back; the high-end scenario assumes a return to pre-disruption trends by the start of Q4. Given that pre-disruption trends were already declining, that framing should not be read as bullish.

The company is also burning cash. Free cash flow was negative $123.7 million over the trailing twelve months, and operating cash flow was negative $27.6 million. Cash on hand is $142.6 million against $423.8 million in total debt. The runway is adequate for now, but a chain that is losing money at the corporate level and bleeding margin at the store level does not have the financial flexibility to ride out an extended sales drought.

Valuation: cheap, but not compellingly so

At a price-to-sales ratio of roughly 1.0x and an enterprise value-to-sales ratio of 0.8x, Sweetgreen looks cheap by historical standards. The stock traded above 8x sales at its peak. But cheap relative to its own past is not the same as cheap relative to its trajectory.

CAVA trades at 5.6x sales and Chipotle at 3.4x. Both are profitable, growing their same-store sales, and expanding margins. Sweetgreen's 1.0x multiple is cheap because it is currently losing money with no visible inflection. The PEG ratio reads 0.36, but that is mechanically low because earnings are negative, not because the growth-to-valuation equation works in the company's favor.

The comparison with Cava is particularly damning. Cava's market cap is 7.2 billion — more than ten times Sweetgreen's. Cava grew its same-store sales at double-digit rates through 2025 and maintained restaurant margins above 21%. Investors are willing to pay a premium for a fast-casual chain that is executing; they are pricing Sweetgreen as a turnaround that hasn't begun.

A valuation at 1x sales on a business with negative EBITDA, declining comps, and shrinking margins is not a bargain. It is a reflection of the fact that the market no longer trusts the growth narrative. The question is whether management can earn that trust back.

What would have to change

The wraps launch and the loyalty program transition (which moved to SG Rewards) are the two operational levers management has pointed to. Wraps provide a cheaper, handheld option to compete with Chipotle and Cava, and the loyalty change is now a full lap in the rearview, making year-over-year comparisons cleaner going forward.

Sequential improvement in traffic — from down 11.2% in Q1 to roughly flat by June — is the single most encouraging data point. If that trend holds, the 7-to-8% full-year comps decline is achievable but not a foundation for growth. Investors need to see positive comparable sales, not just a narrowing decline.

The next earnings report is November 5. That quarter will show whether July and August traffic recovers from the cyclospora disruption, whether wraps sustain volume without further eroding mix, and whether margins can stabilize around the 11% guided range. A quarter of positive comps would materially change the risk-reward. Another quarter of declines would confirm the structural headwind.

The rating: Hold

Sweetgreen is not a buy into panic selling. The panic is real, but the underlying business problems — declining same-store sales, collapsing restaurant margins, negative EBITDA, and an inability to raise prices in inflation — are equally real. The cyclospora outbreak is a temporary overhang on a business that was already struggling.

The valuation has reset, but the operating metrics have not. A stock becomes a dip buy when the multiple compresses faster than the business deteriorates. Here, the multiple compressed because the business deteriorated, and management's guidance suggests the deterioration continues through the end of the year.

Hold. Wait for Q3 to show that traffic recovery post-cyclospora is genuine, that margins have found a floor, and that comparable sales are at least flat. If those conditions materialize by November, the current 1x sales multiple could look like a genuine entry point. Until then, the risk-reward does not support a buy.

What would flip this to a buy: positive same-store sales in Q3 or Q4, restaurant-level margins holding above 12%, and guidance for returning to positive comps in 2027. What would make this worse: another quarter of double-digit comp declines, margin compression below 10%, or cash burn accelerating beyond the current $123 million annualized pace.